Restrictions and fear on the Hormuz Strait have fractured supply chains, especially for primary materials used in pharmaceutical packaging.
- May 2026 — CDMO Opportunities And Threats Report
- In Vivo Gene Editing Is Moving From Promise To Proof
- Why Improving Drug Delivery Remains A Major Opportunity In Oncology
- FDA's Guidance On Cell And Gene CMC Codifies Flexibility
- Strategic Synthesis Of ASGCT And ASCO 2026
- Emerging Technologies In Aseptic Processing: Hype Vs. Operational Reality
- Use Of AI In FDA Inspection Activities: Strategies For Effective Preparation
- A Comparison Of 6 Analytical Validation Guidelines Using Data Envelopment Analysis
CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-1453953422 RNA]( "Detection Of Adapter Dimers In NGS Libraries")
Detection Of Adapter Dimers In NGS LibrariesAccurately identifying low‑level adapter dimers is key. Compare electrophoresis methods to show how different kits detect and resolve small fragments, helping researchers choose the best QC approach.
-
![Car T cells attacking cancer cells-GettyImages-1171781191]( "Accelerate Drug Discovery With Real-Time Cell Interaction Insights")
Accelerate Drug Discovery With Real-Time Cell Interaction InsightsDecoding immune cell interactions reveals critical insights for cancer therapy. Advanced imaging and spectral analysis enable precise identification of synapses, accelerating immuno-oncology research.
-
![GettyImages-2183234647 AAV]( "Scale-Up Of AAV Production In Fixed-Bed Bioreactors")
Scale-Up Of AAV Production In Fixed-Bed BioreactorsConsistent AAV production is critical for manufacturing. See how aligned strategies deliver comparable cell growth, metabolic trends, and rAAV5 titers from development through production.
-
![GettyImages-1590576166 cells, research, lab, assay]( "Rapid Production Of Assay Ready Cells For GPCR Drug Discovery")
Rapid Production Of Assay Ready Cells For GPCR Drug DiscoveryAccelerate drug discovery by leveraging transiently transfected assay-ready cells. This method improves assay sensitivity and reduces variability for GPCRs.
-
![GettyImages-1096502340 lab data]( "Implementing Raman Spectroscopy For Automated Monitoring Of A Cell Culture Bioprocess")
Implementing Raman Spectroscopy For Automated Monitoring Of A Cell Culture BioprocessDiscover how Raman spectroscopy and parallel bioprocessing enable real-time cell culture monitoring, saving time and providing crucial data for process optimization in biopharmaceutical production.
-
![SUS - homogenization]( "Study: Ensuring Homogeneity In Biopharmaceutical Aliquotation")
Study: Ensuring Homogeneity In Biopharmaceutical AliquotationTired of manual manipulation risks in biopharmaceuticals? Discover how automated homogenization ensures consistent cell counts and concentration levels, improving patient safety and process reproducibility.
-
![Thermo Fisher - Peptones]( "The Value Of Peptones For Enhancing Biopharmaceutical Productivity")
The Value Of Peptones For Enhancing Biopharmaceutical ProductivityPeptones, versatile media additives derived from various sources, offer numerous benefits for biopharmaceutical production.
-
![GettyImages-2187764040-cell-culture-testing-manufacturing-in-lab]( "Building A Scalable Global T Cell Manufacturing Platform")
Building A Scalable Global T Cell Manufacturing PlatformAchieve scalable T cell manufacturing with automation, standardized workflows, and integrated quality control to enable high-yield production, flexible scheduling, and seamless tech transfer.
-
![GettyImages-2217581928 manufacturing, production]( "Collaborative Variability Reduction In Cell Culture Media")
Collaborative Variability Reduction In Cell Culture MediaVariability reduction programs improve biomanufacturing by controlling raw‑material complexity, optimizing critical attributes, and boosting productivity through data‑driven partnerships.
-
![CPC - aseptic processing]( "The Case For Modernizing Small-Volume Aseptic Processing")
The Case For Modernizing Small-Volume Aseptic ProcessingTube welding and biosafety cabinets present significant costs and risks for small-volume aseptic processing. Modern single-use aseptic connectors offer a more efficient alternative.
NEWSLETTER ARCHIVE
- 06.22.26 -- Navigating The Next Wave Of AAV Capsid
- 06.22.26 -- CDMO Selection: Start With The Relationship, Not The RFP
- 06.19.26 -- Redefining CAR-T Timing And Patient Access With Allogene Therapeutics' Dr. Zachary Roberts
- 06.18.26 -- Tools And Technologies Enabling Next-Generation Cell Therapies
- 06.18.26 -- Scale Vaccine Production With Proven Cell Culture Solutions
- In Vivo Gene Editing Is Moving From Promise To Proof
- Driving Gene Therapy Beyond Rare Disease Will Define The Next Era Of CGT
- CGT Manufacturing Shifts From Capacity To Strategy
- Dr. Peter Marks On Why Gene Therapy May Need A New Regulatory Playbook
- Regeneron Advances In Vivo Gene Therapy For Hearing Loss
CELL AND GENE CONTENT COLLECTIONS
While there are opportunities to scale, there are also manufacturing gaps, capacity issues, and production timelines that require improvement to do so. And then, of course, there’s cost. Because scale up and scale out are significant to everyone in the sector, we’ve curated insightful editorial that addresses the most important aspects of scalability.
More Content Collections
